Visa Introduces Team Visa Roster Ahead of the Olympic and Paralympic Games Tokyo 2020
13.11.2019 15:00:00 EET | Business Wire | Press release
Visa (NYSE: V), the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, today announced its most diverse roster of athletes on Team Visa Tokyo 2020. Representing 43 countries, the most in Team Visa history, the current roster is comprised of 70+ athletes across 30+ sports, including new additions to The Games: Surfing, Skateboarding and Sport Climbing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005219/en/
Visa Introduces Team Visa Roster Ahead of the Olympic and Paralympic Games Tokyo 2020 (Graphic: Business Wire)
The announcement was made at the Team Visa Summit, hosted at the company’s San Francisco Innovation Center. The Summit offers athletes resources on how to improve financial literacy, benefit from digital payments and elevate their personal brand.
“As one of the longest standing partners of the Olympic and Paralympic Games, Visa looks forward to Tokyo 2020. Set to be the largest Games yet, Tokyo 2020 will feature 7,000 hours of broadcast programming and three billion minutes of streamed content,” said Chris Curtin, chief brand and innovation marketing officer, Visa. “Our Team Visa Tokyo 2020 roster reflects The Games themselves: globally diverse, representative of new emerging sports and larger than ever. We are proud to reveal this year’s Team Visa roster and support these athletes as go for Gold in Tokyo.”
The Team Visa Tokyo 2020 roster includes decorated Olympians (Simone Biles, Gymnastics, USA, Katie Ledecky, Swimming, USA, Daniel Dias, Para Swimming, Brazil and Yelyzaveta Mereshko, Para Swimming, Ukraine), World Champions (Megan Rapinoe, Football, USA, PV Sindhu, Badminton, India, Mariana Pajón, BMX, Colombia and Oksana Masters, Para Cycling, USA) and 16 first-time Olympic and Paralympic hopefuls (Kanoa Igarashi, Surfing, Japan and Poppy Starr Olsen, Skateboarding, Australia and Sean McColl, Sport Climbing, Canada, among others). View the current Team Visa roster for Tokyo 2020 here.
“I am honored to join Team Visa and share the spirit of The Games with these incredible athletes as we prepare for Tokyo 2020," said Simone Biles, four-time Olympic gold medalist, Gymnastics, USA. “The opportunity to compete on the world stage while representing our country is truly an honor, and the encouragement and support we receive from teammates, family, friends, fans and our partners, like Visa, really means a lot as we pursue our lifelong goals and dreams.”
“The Team Visa Summit is a great opportunity to meet and interact with my peers in advance of The Games,” said Kanoa Igarashi, Surfing, Japan. “In hoping to compete at my first Olympic Games, having a family of athletes in Team Visa will help me feel more at home knowing I have a sense of community by my side.”
Team Visa Tokyo 2020
Founded in 2000, Team Visa has championed nearly 500 athletes. Each has been selected based on athletic achievements, character and personal journey, and are representative of many of Visa’s brand values and priorities, including:
- Gender Equality: Since the beginning of Team Visa, on average 54% of Team Visa have been women, including the 41 women athletes for Tokyo 2020, underscoring Visa’s efforts to empower more women athletes and support the development of women’s sports.
- Social Impact: In addition to excelling in their sport, many Team Visa athletes advocate for organizations that help to positively impact their local communities. Alison Cerutti (Beach Volleyball, Brazil) has an organization in Brazil that helps give underserved children in his community access to sports, health services and more. Erick Barrondo (Athletics, Guatemala) has demonstrated a similar dedication to helping youth through a charitable race walk he and his wife started to benefit impoverished children in Guatemala.
- Small Business: Visa is a true advocate for the 30 million small businesses in the U.S. and extends that commitment to its Team Visa athletes. From 19-year-old Poppy Starr Olsen (Skateboarding, Australia), an artist and jewelry maker who has leveraged her business to fund her athletic career, to Megan Rapinoe (Football, USA), whose on-field passion is matched by a commitment to growing her purposeful fashion company, Visa is dedicated to supporting athletes in their businesses endeavors.
To learn more about Visa’s ongoing support of Olympic and Paralympic athletes, visit Visa’s Olympic partnership page.
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device, for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa, visa.com/blog and @VisaNews.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191113005219/en/
Contact information
Media Contacts:
Visa | Sheerin Salimi | shesalim@visa.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
